Acelyrin (SLRN) “confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP ...
Internal QA results show the CMSP:B-5 demonstrated strong agreement with an established measure and can generate a report in ...
ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today confirmed receipt of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results